Diagnostic Ventures is proud to work with leading PhD researchers at Brigham Young University. Our technology has been in development since 2016 and currently targets the identification of sepsis-causing pathogens within 20 minutes without a blood culture.
Originally funded by a $5.2M grant from the National Institute of Health.
This product is under development and not approved for sale. This product is not yet FDA approved.
Blood with bacteria is placed into the disk
Spin the blood
Separate pathogens from interferents via sedimentary forces
Slow at a precise rate to separate plasma from the interferents and prevent remixing
50 Million Sepsis Infections 2
11 Million Sepsis Deaths 2
1 in 5 Deaths caused by Sepsis 3
.png)
.png)
.png)
.png)
.png)
